New hope for tough leukemia: experimental drug eganelisib enters human trials
Disease control
Recruiting now
This early-phase study tests an experimental drug called eganelisib, given alone or with standard chemotherapy (cytarabine), in adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) have returned or not responded to prior treatment. The main goals…
Phase: PHASE1 • Sponsor: Stelexis BioSciences • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC